Fondazione Centro San Raffaele (FCSR) aims to support research in genetics of human disease by funding ten 2-year contracts (collaborazione coordinata e continuativa) for young scientists
Deadline for applications 29 MArch 2019 - Contact person: Alessandra Bragonzi - bragonzi.alessandra@hsr.it
A post-doctoral position on Cystic Fibrosis has become open at the Biosystems and Integrative Sciences Institute @ BioISI, Lisbon.
A course on Epithelial ion transport in the GI tract will be organised on 4-6 July 2019 at the University of Pécs, Hungary
This course is an educational opportunity for young PhDs and basic science oriented MDs in the field of gastroenterology across Europe and combines state-of-the-art lectures with hands-on training in the laboratory. This course is focused on epithelial ion transport. Epithelial ion transports play a fundamental role in the maintenance and integrity of the GI tract.
More information here
Deadline for applications 29 March 2019
The Department of Pediatric Pulmonology, Immunology and Intensive Care Medicine (Director: Prof. Marcus M. Mall) offers a postdoc position for a research project investigating the microbiome as a new therapeutic target for the treatment of chronic lung disease in cystic fibrosis (CF).
Application deadline: 31.08.2018
To carry on its mission, the ECFS is hiring an Administrative and Events coordinator to strengthen the executive team,
Read more
A Lecturer or Senior Lecturer in Bacteriology of Chronic Respiratory Infection (non-clinical) position has become available within the National Heart and Lung Institute Faculty of Medicine - Imperial College London
Deadline for application: 8 July 2018
PhD position in Newcastle, UK - The lnstitutes for Cell & Molecular Biosciences & Cellular Medicine are offering a PhD position in the field of Cystic Fibrosis
Contact person: Dr Mike Gray - m.a.gray@newcastle.ac.uk
Deadline for applications: 18 July 2018
Read more
The German CF association (Mukoviszidose e.V.) will host its annual Scientific Meeting in Bad Salzschlirf (near Fulda)/Germany, on 27 - 28 September 2018
The chairs Olaf Eickmeier (Frankfurt), Barbara Kahl (Münster) and Burkhard Tümmler (Hannover) are working on an exciting programme about “Anti-infective and anti-inflammatory strategies to modulate the CF-microbiome”.
Call for Abstracts
If you are interested to present own data, you can submit an abstract until 15th of June 2018.
All appropriate form sheets, the preliminary programme and registration info are available here
University of Geneva, Switzerland.
As from January 1st 2018, a Post-doctoral Position will be available at the Department of Cell Physiology and Metabolism of the Geneva Medical Faculty.
Application deadline: 15 October 2017.
Contact: Marc Chanson, PhD Associate Professor
Marc.Chanson@unige.ch
Mark your calendar: The 15th ECFS Diagnostic Network Working Group Annual Meeting will take place in St. Gallen, Switzerland, on 08-10 February 2018,
hosted by Jürg Barben.
Israel Annual Cystic Fibrosis Society Conference, 19-21 October 2017
Dan Caesarea, Israel
Detailed programme
The European Cystic Fibrosis Society - Clinical Trial Network (ECFS-CTN) wants to appoint a Project Manager.
The ECFS-CTN is a network of independent specialist Cystic Fibrosis Centres across Europe who have voluntarily formed an alliance to improve the outcome of patients with cystic fibrosis (CF). The aim of the ECFS-CTN is to intensify clinical research in terms of quality and quantity to ensure people with CF have access to effective treatment as quickly as possible.
The coordinating centre of the ECFS-CTN is located in Leuven, at the University Hospital Leuven, and is currently staffed by 1 coordinator, 2 part-time assistants, a Standardisation coordinator (located in Belfast) and a Quality Manager (located in Montpellier). The Project Manager will be involved in the day to day functioning of the network and will work in close collaboration with the ECFS CTN Executive Coordinator.
WHAT WE OFFER
Applications closed
A free live webinar will be organised on 02-03 October 2017.
Aerosolized Agents for Airway Clearance in Cystic Fibrosis: When, How and Why?
